Mode
Text Size
Log in / Sign up

Alternative heart failure diuretics show no mortality benefit but higher risk

Share
Alternative heart failure diuretics show no mortality benefit but higher risk
Photo by KOBU Agency / Unsplash

A large review of 23 clinical trials with over 4,900 heart failure patients compared common diuretics. The study looked at furosemide versus alternatives like torsemide, azosemide, and piretanide. The main goal was to see if any drug could lower the chance of death.

The results showed no clear winner for survival. Patients taking alternative diuretics had about the same risk of death as those on furosemide. There was also no major difference in how often people were hospitalized for any reason. This suggests that for most patients, switching from furosemide may not change these key outcomes.

However, the review found a notable safety issue. Patients on torsemide and piretanide had a higher chance of serious side effects compared to furosemide. The exact number of events was not reported, but the risk was about 30% higher. For body weight, there was no overall difference between the drugs, though one small trial suggested azosemide might lead to slightly more weight loss.

The findings are limited because the trials defined serious side effects differently, and there were not many studies for some comparisons. Doctors should be cautious when considering torsemide or piretanide due to the increased risk of serious problems.

What this means for you:
Alternative diuretics did not improve survival in heart failure, but some raised safety concerns compared to furosemide.
Share
More on Chronic Heart Failure